The cooperation plans to build a co-living portfolio worth Euro 1 billion across Europe within five years with investor capital. As part of the cooperation, CORESTATE will identify, acquire and develop for its clients ideal sites and properties. The focus will be on cities in the German-speaking countries, Spain and Eastern Europe, with over 500,000 inhabitants and real estate with an investment volume of Euro 20 to 60 million. Several properties are already in the pipeline for the new product line. CORESTATE will benefit from its good market access and many years of experience in the micro living sector.

  • Entry into the fast-growing Co-Living segment
  • Planned expansion of a portfolio worth Euro 1 billion
  • Investment volume of Euro 20 to 60 million per property
  • Securing attractive, high-growth revenue structures

December 12, 2018: CORESTATE Capital Holding S.A. (CORESTATE), a leading European real estate investment manager, is expanding its Micro Living offering to include the fast-growing Co-Living segment. CORESTATE has entered into an exclusive partnership with the MEDICI LIVING Group, Europe’s largest provider of innovative co-living concepts.

Under the QUARTERS brand, the MEDICI LIVING Group operates co-living spaces for creative people, Young Professionals and founders worldwide, including in New York, Amsterdam and Berlin. Its units offer users modern design, smart technology, spacious communal areas and regular events.

The cooperation plans to build a co-living portfolio worth Euro 1 billion across Europe within five years with investor capital. As part of the cooperation, CORESTATE will identify, acquire and develop for its clients ideal sites and properties. The focus will be on cities in the German-speaking countries, Spain and Eastern Europe, with over 500,000 inhabitants and real estate with an investment volume of Euro 20 to 60 million. Several properties are already in the pipeline for the new product line. CORESTATE will benefit from its good market access and many years of experience in the micro living sector.

As part of the cooperation, MEDICI LIVING Group will prepare feasibility studies, support CORESTATE in property planning and design and fully assume operation. CORESTATE is securing long-term, high-growth revenue structures for itself and continuing to expand its market position in the trending area of “urban living.”

“Together with MEDICI, we want to play a leading role in shaping the co-living market in Europe. Co-living properties optimally complement our current product range in the micro-living sector. It is a new, rapidly growing residential segment that covers millennials’ rental requirements. They are looking to exchange ideas with like-minded people in a modern living space and experience community, no matter in which metropolis they are currently working. Our investors will also benefit from this trend. Through us, they have the opportunity to invest in a unique product range in the micro-living sector at European level,” says Thomas Landschreiber, CIO and co-founder of CORESTATE.

Gunther Schmidt, founder and CEO of MEDICI LIVING Group, adds: “This partnership is the breakthrough for co-living in Europe”. Gunther Schmidt sees even greater potential for the new asset class than for co-working. “The residential real estate market is much larger than that for office real estate,” he adds. “We are building the WeWork of co-living and CORESTATE’s investors can participate in it.”

About CORESTATE Capital
CORESTATE is an investment manager and co-investor with around € 28 billion in assets under management. The company sees itself as a manager for the entire length of the real estate value chain. Thanks to its fully integrated real estate platform, it is able to offer investors a wide range of services, especially the opportunity to invest in large-scale societal trends such as urbanisation, demographic shifts or sustainability – trends that will continue to have a decisive influence on the living and working environment in the long term. The consistent focus on asset classes that will be successful in the long run constitutes a central cornerstone of the company strategy. At CORESTATE, all concepts are supported with ESG expertise that is unique to the industry. With some 800 experts, CORESTATE offers clients and investors a full range of services and consultation from a single source, from project financing and real estate management to sales. CORESTATE is listed on the Frankfurt Stock Exchange (SDAX) and operates as a respected business partner for institutional and semi-institutional investors as well as high-net-worth private investors in 13 countries across Europe, with offices in Frankfurt, Vienna, Zurich, Paris, Madrid and London.

Forward-looking statements
This press release may contain forward-looking statements. Forward-looking statements are all statements that are not historical facts and events. This applies wherever there is information about future financial profitability, plans and expectations with regard to the company, growth and profitability as well as economic conditions to which the company is exposed. Statements using the words „should“, „may“, „will“, „believes“, „expects“, „assumes“, „assumes“, „estimates“, „plans“, „believes“, „to the knowledge“, „estimates“ or similar expressions indicate such forward-looking statements. Forward-looking statements are based on current estimates and assumptions made by management to the best of their knowledge. Such forward-looking statements are based on assumptions and factors and are subject to uncertainties, the non-occurrence or occurrence of which may cause the actual circumstances, including the Company’s net assets, financial position and results of operations, to differ materially from or be more negative than those expressly or implicitly assumed or described in these statements. Certain forward-looking statements, while appropriate at this time, may prove to be incorrect. Various known and unknown risks, uncertainties and other factors could cause the forward-looking statements, actual results, financial position, development or performance of the Company to be materially different from those expressed or implied by such statements. Therefore, the Company and its management cannot be held responsible for the actual occurrence of the forecasted developments. It should be noted that the Company assumes no obligation to update such forward-looking statements or to conform them to future events or developments.

print